|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 809481-809505 of 2348511 (93941 Page(s) Totally)
<< < 32375 32376 32377 32378 32379 32380 32381 32382 32383 32384 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2019-12-27T01:17:02Z |
Targeting ASIC3 for pain, anxiety, and insulin resistance
|
Wu, Wei-Li; Cheng, Ching-Feng; Sun, Wei-Hsin; Wong, Chia-Wen; Chen, Chih-Cheng; Wu, Wei-Li; Cheng, Ching-Feng; Sun, Wei-Hsin; Wong, Chia-Wen; Chen, Chih-Cheng; WEI-HSIN SUN |
| 國立成功大學 |
2012-11-16 |
Targeting Aurora Kinases in Acute Lymphoblastic Leukemia
|
Chen, YP�(Chen, Ya-Ping)�; �Lin, HJ�(Lin, Hui-Ju); �Chang, KC�(Chang, Kung-Chao)�; �Chen, JS�(Chen, Jiann-Shiuh)�; �Tsai, MY�(Tsai, Ming-Ying)�; Hung, LY�(Hung, Liang-Yi)�; �Chen, TY�(Chen, Tsai-Yun) |
| 中國醫藥大學 |
2012-03 |
Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells
|
(Pei-Ming Chu); (Li-Hsin Chen);(Ming-Teh Chen);(Hsin-I Ma);(Tsann-Long Su);(Pei-Chen Hsieh);(Chian-Shiu Chien);(Bo-Hua Jiang);(Yu-Chih Chen);林宜慧(Yi-Hui Lin);(Yang-Hsin Shih);(Pang-Hsien Tu);(Shih-Hwa Chiou)* |
| 中國醫藥大學 |
2012-03 |
Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells
|
朱培銘(Pei-Ming Chu)*;(Li-Hsin Chen);(Ming-Teh Chen);(Hsin-I Ma)*;(Tsann-Long Su);(Pei-Chen Hsieh);(Chian-Shiu Chien);(Bo-Hua Jiang);(Yu-Chih Chen);(Yi-Hui Lin);(Yang-Hsin Shih);(Pang-Hsien Tu);(Shih-Hwa Chiou)* |
| 中國醫藥大學 |
2012-03 |
Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells
|
朱培銘(Pei-Ming Chu);(Li-Hsin Chen);(Ming-Teh Chen);(Hsin-I Ma)*;(Tsann-Long Su);(Pei-Chen Hsieh);(Chian-Shiu Chien);(Bo-Hua Jiang);(Yu-Chih Chen);林宜慧(Yi-Hui Lin);(Yang-Hsin Shih);(Pang-Hsien Tu);(Shih-Hwa Chiou)* |
| 臺北醫學大學 |
2020-08 |
Targeting BC200/MiR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness.
|
林乾閔; Yu-Kai Su, Jia Wei Lin, Jing-Wen Shih, Hao-Yu Chuang, Iat-Hang Fong, Chi-Tai Yeh, Chien-Min Lin |
| 臺北醫學大學 |
2009 |
Targeting bioactive molecules to mitochondria
|
Mike Murphy |
| 國立成功大學 |
2023-04-14 |
Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis
|
Hsu;-Ling, Pei;Chien;-Wei, Chun;Tang;Yen-An;Lin;-Wen, Bo;Lin;Shih-Chieh;Lin;Yi-Syuan;Chen;Sih-Yu;Sun;Sunny, H.;Tsai;Shaw-Jenq |
| 臺大學術典藏 |
2021-07-07T05:13:05Z |
Targeting breast cancer stem cells by novel HDAC3-selective inhibitors
|
Hsieh H.-Y.; Chuang H.-C.; Shen F.-H.; Detroja K.; LING-WEI HSIN; Chen C.-S. |
| 國家衛生研究院 |
2014-09 |
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor
|
Guo, W;Liu, R;Bhardwaj, G;Yang, JC;Changou, C;Ma, AH;Mazloom, A;Chintapalli, S;Xiao, K;Xiao, W;Kumaresan, P;Sanchez, E;Yeh, CT;Evans, CP;Patterson, R;Lam, KS;Kung, HJ |
| 國家衛生研究院 |
2023-09 |
Targeting Ca(2+)-dependent pathways to promote corneal epithelial wound healing induced by CISD2 deficiency
|
Sun, CC;Lee, SY;Chen, LH;Lai, CH;Shen, ZQ;Chen, NN;Lai, YS;Tung, CY;Tzeng, TY;Chiu, WT;Tsai, TF |
| 國立成功大學 |
2023 |
Targeting Ca2+-dependent pathways to promote corneal epithelial wound healing induced by CISD2 deficiency
|
Sun, C.-C.;Lee, S.-Y.;Chen, L.-H.;Lai, C.-H.;Shen, Z.-Q.;Chen, N.-N.;Lai, Y.-S.;Tung, C.-Y.;Tzeng, Tzeng T.-Y.;Chiu, W.-T.;Tsai, Tsai T.-F. |
| 國立成功大學 |
2024-06 |
Targeting Ca2+-dependent pathways to promote corneal epithelial wound healing induced by CISD2 deficiency
|
Sun;Chi-Chin;Lee;Shao-Yun;Chen;Li-Hsien;Lai;Jia-Hui;Shen;Zhao-Qing;Chen;Ni, Nan;Chiu;Wen-Tai;Tsai;Ting-Fen |
| 臺北醫學大學 |
2015 |
Targeting cancer stem cells in breast cancer: the potential anticancer properties of 6-shogaol and pterostilbene
|
CH, Wu;BH, Hon;CT, Ho;GC, Yen |
| 臺北醫學大學 |
2015 |
Targeting cancer stem cells in breast cancer: the potential anticancer properties of 6-shogaol and pterostilbene
|
Wu, CH;Hon, BH;Ho, CT;Yen, GC |
| 國家衛生研究院 |
2024-03-07 |
Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer
|
Ma, L;Chen, C;Zhao, CX;Li, T;Ma, LY;Jiang, JY;Duan, ZJ;Si, Q;Chuang, TH;Xiang, R;Luo, YP |
| 國家衛生研究院 |
2012-04 |
Targeting cathepsin S induces tumor cell autophagy via the EGFR-Erk signaling pathway
|
Chen, KL;Chang, WS;Cheung, CH;Lin, CC;Huang, CC;Yang, YN;Kuo, CP;Kuo, CC;Chang, YH;Liu, KJ;Wu, CM;Chang, JY |
| 國家衛生研究院 |
2011-04 |
Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway
|
Chen, KL;Chang, WSW;Lin, CC;Cheung, CHA;Kuo, CP;Kuo, CC;Chang, YH;Liu, KJ;Chang, JY |
| 國立成功大學 |
2012-04-01 |
Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway
|
Chen, Kuo-Li; Chang, Wun-Shaing Wayne; Cheung, Chun Hei Antonio; Lin, Chun-Cheng; Huang, Chien-Chang; Yang, Yung-Ning; Kuo, Chang-Po; Kuo, Ching-Chuan; Chang, Yi-Hsun; Liu, Ko-Jiunn; Wu, Ching-Ming; Chang, Jang-Yang |
| 國家衛生研究院 |
2024-05-09 |
Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function
|
Lee, HW;Chen, SJ;Tsai, KJ;Hsu, KS;Chen, YF;Chang, CH;Lin, HH;Hsueh, WY;Hsieh, HP;Lee, YF;Chiang, HC;Chang, JY |
| 國立成功大學 |
2024-05-9 |
Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function
|
Lee;Hao-Wei;Chen;Szu-Jung;Tsai;Kuen-Jer;Hsu;Kuei-Sen;Chen;Yi-Fan;Chang;Chih-Hua;Lin;Hsiao-Han;Hsueh;Wen-Yun;Hsieh;Hsing-Pang;Lee;Yueh-Feng;Chiang;Huai-Chueh;Chang;Jang-Yang |
| 中山醫學大學 |
2015-06-04 |
Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells.
|
CC, Yu;FW, Hu;CH, Yu;MY, Chou |
| 臺大學術典藏 |
2022-02-21T02:51:54Z |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali P.A.; Lin C.-C.; Carthon B.C.; Bauer T.M.; Tucci M.; Italiano A.; Iacovelli R.; Su W.-C.; Massard C.; Saleh M.; Daniele G.; Greystoke A.; Gutierrez M.; Pant S.; YING-CHUN SHEN; Perrino M.; Meng R.; Abbadessa G.; Lee H.; Dong Y.; Chiron M.; Wang R.; Loumagne L.; L?pine L.; De Bono J. |
| 臺大學術典藏 |
2022-02-21T23:31:30Z |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali, Paolo Andrea; Chia-Chi Lin; Carthon, Bradley C.; Bauer, Todd M.; Tucci, Marcello; Italiano, Antoine; Iacovelli, Roberto; Su, Wu Chou; Massard, Christophe; Saleh, Mansoor; Daniele, Gennaro; Greystoke, Alastair; Gutierrez, Martin; Pant, Shubham; YING-CHUN SHEN; Perrino, Matteo; Meng, Robin; Abbadessa, Giovanni; Lee, Helen; Dong, Yingwen; Chiron, Marielle; Wang, Rui; Loumagne, Laure; Lépine, Lucie; De Bono, Johann |
| 臺大學術典藏 |
2022-09-15T01:08:45Z |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali P.A.; Chia-Chi Lin; Carthon B.C.; Bauer T.M.; Tucci M.; Italiano A.; Iacovelli R.; Su W.-C.; Massard C.; Saleh M.; Daniele G.; Greystoke A.; Gutierrez M.; Pant S.; Shen Y.-C.; Perrino M.; Meng R.; Abbadessa G.; Lee H.; Dong Y.; Chiron M.; Wang R.; Loumagne L.; L?pine L.; De Bono J. |
Showing items 809481-809505 of 2348511 (93941 Page(s) Totally)
<< < 32375 32376 32377 32378 32379 32380 32381 32382 32383 32384 > >>
View [10|25|50] records per page
|
